Ayumi Ide

843 total citations
11 papers, 719 citations indexed

About

Ayumi Ide is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Ayumi Ide has authored 11 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Ayumi Ide's work include Renin-Angiotensin System Studies (7 papers), Receptor Mechanisms and Signaling (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Ayumi Ide is often cited by papers focused on Renin-Angiotensin System Studies (7 papers), Receptor Mechanisms and Signaling (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Ayumi Ide collaborates with scholars based in Japan. Ayumi Ide's co-authors include Masaru Iwai, Masatsugu Horiuchi, Masaki Mogi, Rui Chen, Tetsuya Shiuchi, Midori Okumura, Li‐Juan Min, Jun Suzuki, Ryuji Hata and Masahiro Sakanaka and has published in prestigious journals such as Circulation, Hypertension and European Journal of Pharmacology.

In The Last Decade

Ayumi Ide

11 papers receiving 705 citations

Peers

Ayumi Ide
Delyth Graham United Kingdom
Pablo Nakagawa United States
Sarah Vargas United States
Frank Leijten Netherlands
Nobuyo Maeda United States
Jane Stubbe Denmark
Ayumi Ide
Citations per year, relative to Ayumi Ide Ayumi Ide (= 1×) peers Carole Amant

Countries citing papers authored by Ayumi Ide

Since Specialization
Citations

This map shows the geographic impact of Ayumi Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayumi Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayumi Ide more than expected).

Fields of papers citing papers by Ayumi Ide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayumi Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayumi Ide. The network helps show where Ayumi Ide may publish in the future.

Co-authorship network of co-authors of Ayumi Ide

This figure shows the co-authorship network connecting the top 25 collaborators of Ayumi Ide. A scholar is included among the top collaborators of Ayumi Ide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayumi Ide. Ayumi Ide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Iwanami, Jun, Masaki Mogi, Xinyu Gao, et al.. (2007). Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model. European Journal of Pharmacology. 566(1-3). 153–159. 36 indexed citations
2.
Mizoue, Shiro, Masaru Iwai, Ayumi Ide, et al.. (2006). Role of Angiotensin II Receptor Subtypes in Conjunctival Wound Healing. Current Eye Research. 31(2). 129–136. 16 indexed citations
3.
Yoshii, Toyofumi, Masaru Iwai, Zhen Li, et al.. (2006). Regression of Atherosclerosis by Amlodipine via Anti-Inflammatory and Anti-Oxidative Stress Actions. Hypertension Research. 29(6). 457–466. 66 indexed citations
4.
Hamai, Meiko, Masaru Iwai, Ayumi Ide, et al.. (2006). Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress. Neuropharmacology. 51(4). 822–828. 43 indexed citations
5.
Iwai, Masaru, Rui Chen, Ayumi Ide, et al.. (2006). The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage. Journal of Hypertension. 24(10). 2023–2031. 20 indexed citations
6.
Oshita, Akira, Masaru Iwai, Rui Chen, et al.. (2006). Attenuation of Inflammatory Vascular Remodeling by Angiotensin II Type 1 Receptor–Associated Protein. Hypertension. 48(4). 671–676. 42 indexed citations
7.
Tsuda, Masahiro, Masaru Iwai, Jian‐Mei Li, et al.. (2005). Inhibitory Effects of AT 1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress. Hypertension. 45(4). 545–551. 98 indexed citations
8.
Suzuki, Jun, Masaru Iwai, Zhen Li, et al.. (2005). Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice. Journal of Hypertension. 23(7). 1383–1389. 43 indexed citations
9.
Okumura, Midori, Masaru Iwai, Ayumi Ide, et al.. (2005). Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT 2 Receptor Expression. Hypertension. 46(3). 577–583. 45 indexed citations
10.
Iwai, Masaru, Rui Chen, Zhen Li, et al.. (2005). Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice. Circulation. 112(11). 1636–1643. 101 indexed citations
11.
Iwai, Masaru, Hongwei Liu, Rui Chen, et al.. (2004). Possible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation. Circulation. 110(7). 843–848. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026